Michael A. Mahr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael A. Mahr has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
David O. Hodge
From Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota (Erie, Mahr); Department of Quantitative Health Science, Mayo Clinic, Jacksonville, Florida (Hodge)
4 shared publicationsJay C. Erie
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota
4 shared publications- Jay C. Erie
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA
2 shared publications - Andrew J. Barkmeier
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota
1 shared publication - Danielle Fujino
American Academy of Ophthalmology, San Francisco, California
1 shared publication David C. Herman
1 shared publication
Latest Publications
- 1 June 2022
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (6) , 717-722
Prevalence of pseudophakia: U.S. population–based study
Purpose: To determine the current prevalence and trends of pseudophakia in a well-defined U.S. population, calculating values for Olmsted County, Minnesota, from 1988 through 2018. Setting: Mayo Clinic, Rochester, Minnesota. Design: Population-based cohort study. Methods: Rochester Epidemiology Project (REP) databases were used to identify all cases of pseudophakia in Olmsted County, Minnesota, between January 1, 1988, and December 31, 2018. Age- and sex-specific prevalence rates were calculated in 1988, 1998, 2008, and 2018 using REP census population estimates and mortality counts. Poisson regression analysis was used to assess changes in prevalence over time. Mortality rates were estimated by Kaplan-Meier analysis. Results: In 2018, 10 024 county residents were pseudophakic in at least 1 eye, for a total population prevalence of 6.5%. The prevalence increased 67% in the last 10 years and 590% in the last 30 years (P < .001). By 2018, 51% of residents aged 75 years and 88% of residents aged 85 years and older were pseudophakic in at least 1 eye, 53% of residents with pseudophakia aged 65 years and older were bilaterally pseudophakic, and 29% of residents with pseudophakia had lived with pseudophakia for more than 10 years. The prevalence was higher among women than men and increased with age (P < .001). Overall, pseudophakia had a lower all-cause mortality compared with the general Minnesota population (P < .001). Conclusions: In 2018, most residents aged 75 years and older were pseudophakic in at least 1 eye. These numbers underscore the changing visual status of older adults and the large number of adults who benefit from cataract surgery.
- 1 June 2022
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (6) , 717-722
Prevalence of pseudophakia: U.S. population–based study
Purpose: To determine the current prevalence and trends of pseudophakia in a well-defined U.S. population, calculating values for Olmsted County, Minnesota, from 1988 through 2018. Setting: Mayo Clinic, Rochester, Minnesota. Design: Population-based cohort study. Methods: Rochester Epidemiology Project (REP) databases were used to identify all cases of pseudophakia in Olmsted County, Minnesota, between January 1, 1988, and December 31, 2018. Age- and sex-specific prevalence rates were calculated in 1988, 1998, 2008, and 2018 using REP census population estimates and mortality counts. Poisson regression analysis was used to assess changes in prevalence over time. Mortality rates were estimated by Kaplan-Meier analysis. Results: In 2018, 10 024 county residents were pseudophakic in at least 1 eye, for a total population prevalence of 6.5%. The prevalence increased 67% in the last 10 years and 590% in the last 30 years (P < .001). By 2018, 51% of residents aged 75 years and 88% of residents aged 85 years and older were pseudophakic in at least 1 eye, 53% of residents with pseudophakia aged 65 years and older were bilaterally pseudophakic, and 29% of residents with pseudophakia had lived with pseudophakia for more than 10 years. The prevalence was higher among women than men and increased with age (P < .001). Overall, pseudophakia had a lower all-cause mortality compared with the general Minnesota population (P < .001). Conclusions: In 2018, most residents aged 75 years and older were pseudophakic in at least 1 eye. These numbers underscore the changing visual status of older adults and the large number of adults who benefit from cataract surgery.
- 21 September 2021
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (1) , 95-99
Effect of a 7.0 mm intraocular lens optic on peripheral retinal illumination with implications for negative dysphotopsia
Purpose: To use optical modeling to compare a 6.0 mm and 7.0 mm intraocular lens (IOL) optic diameters on peripheral retinal illumination with implications for negative dysphotopsia. Setting: Mayo Clinic, Rochester, Minnesota, and Simpson Optics LLC, Arlington, Texas. Design: Model eye. Methods: Ray-tracing software was used to simulate retinal illumination from an extended light source for a pseudophakic eye with in-the-bag biconvex IOLs (refractive index [n] = 1.46 and 1.55) and a 2.5 mm pupil. Ray-tracing diagrams and simulated retina illumination profiles were compared using the 6.0 mm and 7.0 mm optic diameter IOLs. Retinal locations were scaled to relative visual angles from 70 to 110 degrees horizontally. Results: A 7.0 mm optic (n = 1.46) expands the image field by 2.8 degrees compared with a 6.0 mm optic. High-angle input light misses a 7.0 mm optic at a larger visual angle than a 6.0 mm optic, shifting illumination of the peripheral retina by this light anteriorly by 5.6 degrees. Consequently, a region of nonilluminated peripheral nasal retina is enlarged and shifted peripherally using a 7.0 mm optic (visual angle, 86.3 to 96.3 degrees) compared with a 6.0 mm optic (visual angle, 83.5 to 90.7 degrees). Similar illumination changes were seen modeling a 1.55 n IOL. Conclusions: A narrow dark region in the nasal retina when using a 6.0 mm optic is changed to a broader, more peripheral dark region when using a 7.0 mm optic. An extended, more peripheral dark nasal region may make a temporal shadow less bothersome and explain lower negative dysphotopsia rates using a 7.0 mm optic.
- 21 September 2021
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (1) , 95-99
Effect of a 7.0 mm intraocular lens optic on peripheral retinal illumination with implications for negative dysphotopsia
Purpose: To use optical modeling to compare a 6.0 mm and 7.0 mm intraocular lens (IOL) optic diameters on peripheral retinal illumination with implications for negative dysphotopsia. Setting: Mayo Clinic, Rochester, Minnesota, and Simpson Optics LLC, Arlington, Texas. Design: Model eye. Methods: Ray-tracing software was used to simulate retinal illumination from an extended light source for a pseudophakic eye with in-the-bag biconvex IOLs (refractive index [n] = 1.46 and 1.55) and a 2.5 mm pupil. Ray-tracing diagrams and simulated retina illumination profiles were compared using the 6.0 mm and 7.0 mm optic diameter IOLs. Retinal locations were scaled to relative visual angles from 70 to 110 degrees horizontally. Results: A 7.0 mm optic (n = 1.46) expands the image field by 2.8 degrees compared with a 6.0 mm optic. High-angle input light misses a 7.0 mm optic at a larger visual angle than a 6.0 mm optic, shifting illumination of the peripheral retina by this light anteriorly by 5.6 degrees. Consequently, a region of nonilluminated peripheral nasal retina is enlarged and shifted peripherally using a 7.0 mm optic (visual angle, 86.3 to 96.3 degrees) compared with a 6.0 mm optic (visual angle, 83.5 to 90.7 degrees). Similar illumination changes were seen modeling a 1.55 n IOL. Conclusions: A narrow dark region in the nasal retina when using a 6.0 mm optic is changed to a broader, more peripheral dark region when using a 7.0 mm optic. An extended, more peripheral dark nasal region may make a temporal shadow less bothersome and explain lower negative dysphotopsia rates using a 7.0 mm optic.
- 1 May 2020
- Published by Elsevier in Ophthalmology
- Vol. 127 (5) , 698-699
Return to the Operating Room for Removal of Retained Lens Fragments after Cataract Surgery: IRIS® Registry (Intelligent Research in Sight) Analysis
- 1 May 2020
- Published by Elsevier in Ophthalmology
- Vol. 127 (5) , 698-699
Return to the Operating Room for Removal of Retained Lens Fragments after Cataract Surgery: IRIS® Registry (Intelligent Research in Sight) Analysis
- 1 March 2020
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 46 (3) , 372-377
Angle alpha orientation and magnitude distribution in a cataract surgery population
Purpose: To report normative angle alpha orientation and magnitude distribution in a cataract surgery patient population. Setting: U.S. academic medical center. Design: Retrospective review. Methods: A total of 11 871 wavefront aberrometer/corneal topographer angle alpha measurements were performed over 40 months, yielding 8773 bilateral measurements (73.9%) with zero bad wavefront datapoints. The analysis was limited to the first right-eye scan for 3382 unique patients. The angle alpha magnitudes (millimeters) and orientations (degrees) were analyzed for these unique right eyes. Results: For the 3,382 unique patients, the mean angle alpha magnitude was 0.44 ± 0.15 mm (median, 0.44 mm; 25th and 75th percentiles 0.34 mm, 0.53 mm). Angle alpha orientation was predominantly horizontal (P < .01), with a mean of 186 ± 32 degrees. The expected point of intraocular lens (IOL) centration (EPIC) based on the geometric center of the corneal limbus was temporal to the visual axis in 3212 eyes (95%), nasal in 92 eyes (2.7%), inferior in 56 eyes (1.7%), and superior in 22 eyes (0.6%). The mean angle alpha magnitude was 0.3 mm or less in 607 eyes (18%) and 0.5 mm or greater in 1089 eyes (32%). Conclusions: Angle alpha is a predominantly horizontal phenomenon with a mean EPIC of 0.44 mm temporal to the visual axis. This information may assist in determining eligibility for patients in multifocal IOL implantation.
- 1 March 2020
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 46 (3) , 372-377
Angle alpha orientation and magnitude distribution in a cataract surgery population
Purpose: To report normative angle alpha orientation and magnitude distribution in a cataract surgery patient population. Setting: U.S. academic medical center. Design: Retrospective review. Methods: A total of 11 871 wavefront aberrometer/corneal topographer angle alpha measurements were performed over 40 months, yielding 8773 bilateral measurements (73.9%) with zero bad wavefront datapoints. The analysis was limited to the first right-eye scan for 3382 unique patients. The angle alpha magnitudes (millimeters) and orientations (degrees) were analyzed for these unique right eyes. Results: For the 3,382 unique patients, the mean angle alpha magnitude was 0.44 ± 0.15 mm (median, 0.44 mm; 25th and 75th percentiles 0.34 mm, 0.53 mm). Angle alpha orientation was predominantly horizontal (P < .01), with a mean of 186 ± 32 degrees. The expected point of intraocular lens (IOL) centration (EPIC) based on the geometric center of the corneal limbus was temporal to the visual axis in 3212 eyes (95%), nasal in 92 eyes (2.7%), inferior in 56 eyes (1.7%), and superior in 22 eyes (0.6%). The mean angle alpha magnitude was 0.3 mm or less in 607 eyes (18%) and 0.5 mm or greater in 1089 eyes (32%). Conclusions: Angle alpha is a predominantly horizontal phenomenon with a mean EPIC of 0.44 mm temporal to the visual axis. This information may assist in determining eligibility for patients in multifocal IOL implantation.
- 1 December 2018
- Published by Elsevier in Ophthalmology Retina
- Vol. 2 (12) , 1188-1195
Racial Differences in Age-Related Macular Degeneration and Associated Anti–Vascular Endothelial Growth Factor Intravitreal Injections among Medicare Beneficiaries
- 1 December 2018
- Published by Elsevier in Ophthalmology Retina
- Vol. 2 (12) , 1188-1195
Racial Differences in Age-Related Macular Degeneration and Associated Anti–Vascular Endothelial Growth Factor Intravitreal Injections among Medicare Beneficiaries
- 1 June 2017
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 92 (6) , 870-880
Gender Differences in Physician Service Provision Using Medicare Claims Data
- 1 June 2017
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 92 (6) , 870-880
Gender Differences in Physician Service Provision Using Medicare Claims Data
- Open Access
- 1 October 2016
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 134 (10) , 1178-1180
Racial/Ethnic Differences in Rates of Penetrating or Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy Among US Medicare Beneficiaries
As the most common cause for endothelial and penetrating keratoplasty in the United States, Fuchs endothelial corneal dystrophy (FECD) is likely to have varied phenotypic expressions.1,2 National claims research shows that African American patients are as likely or more likely to have a diagnosis of FECD relative to white patients.3 A regional study also showed that African American patients and white patients receive diagnoses of guttae at similar rates, but white patients are more likely to have more severe disease in the form of confluent guttae.2,4 Previous attempts to genetically characterize FECD in African American individuals have failed to discern a genetic association relative to a broader population.5 Our aim was to use a national cross-sectional Medicare data set to test for racial/ethnic differences in the rates of penetrating or endothelial keratoplasty in FECD.
- 1 October 2016
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 134 (10) , 1178-1180
Open AccessRacial/Ethnic Differences in Rates of Penetrating or Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy Among US Medicare Beneficiaries
As the most common cause for endothelial and penetrating keratoplasty in the United States, Fuchs endothelial corneal dystrophy (FECD) is likely to have varied phenotypic expressions.1,2 National claims research shows that African American patients are as likely or more likely to have a diagnosis of FECD relative to white patients.3 A regional study also showed that African American patients and white patients receive diagnoses of guttae at similar rates, but white patients are more likely to have more severe disease in the form of confluent guttae.2,4 Previous attempts to genetically characterize FECD in African American individuals have failed to discern a genetic association relative to a broader population.5 Our aim was to use a national cross-sectional Medicare data set to test for racial/ethnic differences in the rates of penetrating or endothelial keratoplasty in FECD.
- 1 June 2008
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 34 (6) , 980-985
Construct validity of anterior segment anti-tremor and forceps surgical simulator training modules
To compare the performance of the anterior segment forceps and anti-tremor training modules of the EYESi surgical simulator (VRmagic) by residents and experienced attending surgeons using the simulator for the first time. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA. Twelve residents (4 per year) in the Mayo Clinic ophthalmology residency program and 3 experienced anterior segment surgeons participated. Each participant completed a total of 20 task trials on the EYESi forceps and anti-tremor level 4 training modules. Thus, the 15 participants completed a total of 300 task trials. For the forceps module, experienced surgeons achieved significantly better total scores (P = .03), with lower total task time (P = .007) and instrument-in-eye time (P = .006) measurements. For the anti-tremor module, experienced surgeons achieved significantly better total scores (P = .02), with lower task time (P = .04) and instrument-in-eye time (P = .02) measurements. In addition, experienced surgeons performing the anti-tremor task had 76% more precise surgical outcomes as measured by the out-of-tolerance percentage (P = .03). All forceps and anti-tremor-measured parameters indicated significantly lower performance (P< .05) for the first 1 or 2 trials, with the exception of anti-tremor module incision stress, out-of-tolerance percentage, and average tremor values. Experienced surgeons had more consistent (lower variance) total scores on the forceps (P = .05) and anti-tremor (P = .03) training modules. The EYESi surgical simulator anterior segment forceps and anti-tremor modules showed significant (P< .05) construct validity.
- 1 June 2008
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 34 (6) , 980-985
Construct validity of anterior segment anti-tremor and forceps surgical simulator training modules
To compare the performance of the anterior segment forceps and anti-tremor training modules of the EYESi surgical simulator (VRmagic) by residents and experienced attending surgeons using the simulator for the first time. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA. Twelve residents (4 per year) in the Mayo Clinic ophthalmology residency program and 3 experienced anterior segment surgeons participated. Each participant completed a total of 20 task trials on the EYESi forceps and anti-tremor level 4 training modules. Thus, the 15 participants completed a total of 300 task trials. For the forceps module, experienced surgeons achieved significantly better total scores (P = .03), with lower total task time (P = .007) and instrument-in-eye time (P = .006) measurements. For the anti-tremor module, experienced surgeons achieved significantly better total scores (P = .02), with lower task time (P = .04) and instrument-in-eye time (P = .02) measurements. In addition, experienced surgeons performing the anti-tremor task had 76% more precise surgical outcomes as measured by the out-of-tolerance percentage (P = .03). All forceps and anti-tremor-measured parameters indicated significantly lower performance (P< .05) for the first 1 or 2 trials, with the exception of anti-tremor module incision stress, out-of-tolerance percentage, and average tremor values. Experienced surgeons had more consistent (lower variance) total scores on the forceps (P = .05) and anti-tremor (P = .03) training modules. The EYESi surgical simulator anterior segment forceps and anti-tremor modules showed significant (P< .05) construct validity.
- Open Access
- 1 January 2003
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 121 (1) , 122
Ocular Hypotony Secondary to Spontaneously Ruptured Posterior Staphyloma
We describe a woman with ocular hypotony secondary to a spontaneously ruptured posterior staphyloma. The staphyloma was effectively treated with a retrobulbar i
- 1 January 2003
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 121 (1) , 122
Open AccessOcular Hypotony Secondary to Spontaneously Ruptured Posterior Staphyloma
We describe a woman with ocular hypotony secondary to a spontaneously ruptured posterior staphyloma. The staphyloma was effectively treated with a retrobulbar i